Interviews Jens Lindberg, CEO Medivir at the Swiss Nordic Bio conference in Zürich, Switzerland - Jens Lindberg, CEO, Medivir 00:00:00
25 years of experience from pharmaceutical industry spanning global and local responsibilities. Has led product strategy development for late stage compounds preparing for regulatory approval and commercialisation as well as execution of launch for multiple compounds in specialty care. Primary area of focus in the past 10 years in the field of Oncology. Experience also includes interim CEO role for Sedana Medical AB and Director Investor Relations at AstraZeneca.
